1. Home
  2. MYNZ vs ADN Comparison

MYNZ vs ADN Comparison

Compare MYNZ & ADN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MYNZ
  • ADN
  • Stock Information
  • Founded
  • MYNZ 2021
  • ADN 2006
  • Country
  • MYNZ Germany
  • ADN United States
  • Employees
  • MYNZ N/A
  • ADN N/A
  • Industry
  • MYNZ Biotechnology: Pharmaceutical Preparations
  • ADN Power Generation
  • Sector
  • MYNZ Health Care
  • ADN Utilities
  • Exchange
  • MYNZ Nasdaq
  • ADN Nasdaq
  • Market Cap
  • MYNZ 9.8M
  • ADN 11.2M
  • IPO Year
  • MYNZ 2021
  • ADN N/A
  • Fundamental
  • Price
  • MYNZ $0.35
  • ADN $4.64
  • Analyst Decision
  • MYNZ Buy
  • ADN Hold
  • Analyst Count
  • MYNZ 2
  • ADN 1
  • Target Price
  • MYNZ $3.00
  • ADN $18.00
  • AVG Volume (30 Days)
  • MYNZ 1.4M
  • ADN 27.1K
  • Earning Date
  • MYNZ 08-13-2024
  • ADN 09-23-2024
  • Dividend Yield
  • MYNZ N/A
  • ADN N/A
  • EPS Growth
  • MYNZ N/A
  • ADN N/A
  • EPS
  • MYNZ N/A
  • ADN N/A
  • Revenue
  • MYNZ $895,479.00
  • ADN $5,310,000.00
  • Revenue This Year
  • MYNZ $67.40
  • ADN N/A
  • Revenue Next Year
  • MYNZ $191.13
  • ADN $2,705.94
  • P/E Ratio
  • MYNZ N/A
  • ADN N/A
  • Revenue Growth
  • MYNZ 69.00
  • ADN N/A
  • 52 Week Low
  • MYNZ $0.32
  • ADN $2.70
  • 52 Week High
  • MYNZ $4.71
  • ADN $27.72
  • Technical
  • Relative Strength Index (RSI)
  • MYNZ 39.09
  • ADN 69.89
  • Support Level
  • MYNZ $0.34
  • ADN $3.70
  • Resistance Level
  • MYNZ $0.46
  • ADN $4.74
  • Average True Range (ATR)
  • MYNZ 0.07
  • ADN 0.43
  • MACD
  • MYNZ 0.00
  • ADN 0.13
  • Stochastic Oscillator
  • MYNZ 10.83
  • ADN 86.13

About MYNZ Mainz Biomed N.V.

Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples.

About ADN Advent Technologies Holdings Inc.

Advent Technologies Holdings Inc is an innovation-driven company in the fuel cell and hydrogen technology space. The company develops, manufactures, and assembles complete fuel cell systems and the critical components that determine the performance of hydrogen fuel cells and other energy systems. It serves automotive; aviation and power generation industries. It generates revenue from the sale of fuel cell systems and the sale of MEAs, membranes, and electrodes for specific applications in the fuel cell and energy storage (flow battery) markets.

Share on Social Networks: